Will we one day see a more effective alternative to chemotherapy and more recently immunotherapy to fight cancer? Promising results published in the journal Annals of Oncology by team Pr: Benjamin Bessen from the Institut Gustave-Roussy (Val-de-Marne), in collaboration with the company OSE Immunotherapeutics based in Nantes, makes it possible to observe a type of lung cancer.
At the end of a phase 3 clinical trial, their work shows that their “therapeutic vaccine” The name Tedopi reduces the risk of death after one year in patients with metastatic, stable lung cancer by 41%, compared with standard chemotherapy treatment.
Let’s remind that cancer is a disease that in most cases is not directly related to pathogenic infection. Cancer develops when errors occur in the copying of genetic inheritance that occurs during cell division. “There…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.